TARDOXAL Trademark

Trademark Overview

On Tuesday, July 30, 2019, a trademark application was filed for TARDOXAL with the United States Patent and Trademark Office. The USPTO has given the TARDOXAL trademark a serial number of 88550596. The federal status of this trademark filing is CANCELLED - SECTION 7 as of Thursday, December 18, 2025. This trademark is owned by Medicure Inc.. The TARDOXAL trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of movement disorders
tardoxal

General Information

Serial Number88550596
Word MarkTARDOXAL
Filing DateTuesday, July 30, 2019
Status711 - CANCELLED - SECTION 7
Status DateThursday, December 18, 2025
Registration Number5990240
Registration DateTuesday, February 18, 2020
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, December 3, 2019

Trademark Statements

Goods and ServicesPharmaceutical preparations for the treatment of movement disorders

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code1 - Sec. 7(d) - Entire Registration
Class Status DateThursday, December 18, 2025
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameMedicure Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressWinnipeg, Manitoba R3T0P4
CA
Party NameMedicure Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressWinnipeg, Manitoba R3T0P4
CA
Party NameMedicure Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressWinnipeg, Manitoba R3T0P4
CA

Trademark Events

Event DateEvent Description
Friday, August 2, 2019NEW APPLICATION ENTERED
Sunday, August 11, 2019NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, October 24, 2019ASSIGNED TO EXAMINER
Thursday, October 24, 2019TEAS CHANGE OF OWNER ADDRESS RECEIVED
Thursday, October 24, 2019APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Tuesday, October 29, 2019APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, November 13, 2019NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, December 3, 2019PUBLISHED FOR OPPOSITION
Tuesday, December 3, 2019OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, February 18, 2020REGISTERED-PRINCIPAL REGISTER
Tuesday, February 18, 2025COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Tuesday, September 30, 2025TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, September 30, 2025APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Tuesday, September 30, 2025TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, September 30, 2025ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, September 30, 2025TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, September 30, 2025TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Wednesday, November 19, 2025TEAS SECTION 7 SURRENDER RECEIVED
Monday, December 15, 2025CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Monday, December 15, 2025POST REGISTRATION ACTION MAILED - SEC. 7
Wednesday, December 17, 2025TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED
Wednesday, November 19, 2025REQUEST FOR SECT 7 TOTAL SURRENDER FILED
Thursday, December 18, 2025CANCELLED SECTION 7-TOTAL
Thursday, December 18, 2025NOTICE OF CANCELLATION SEC. 7 SURRENDER EMAILED

Related Keywords

tardoxal disorders movement treatment preparations pharmaceutical